COVID-19 Information

Dr. Robert Insoft Has Been Named to American Academy of Pediatrics Committee

Release Date: 05/02/2016

Robert M. Insoft, MD, a neonatologist at Women & Infants Hospital of Rhode Island, a Care New England hospital, and associate professor of pediatrics at The Warren Alpert Medical School of Brown University, has been appointed to the American Academy of Pediatrics’ Section on Neonatal Perinatal Medicine Steering Committee for the Task Force for Guidelines and Protocol Sharing. Dr. Insoft is also senior vice president and chief medical officer at Women & Infants.

According to Dr. Insoft, “This newly-established committee is charged with the development and publishing of evidence-based clinical guidelines for neonatal medicine nationwide and internationally. It is an honor and a privilege to work with my colleagues from across the nation on ensuring the safest, most effective treatment protocols for some of our tiniest and most vulnerable patients.”

Dr. Insoft is an academic pediatrician and neonatologist whose time has been divided among patient care, clinical research, health policy, quality improvement, administration and teaching. Prior to joining Women & Infants, he served as the medical director of the Neonatal Intensive Care Unit (NICU) and Neonatal Respiratory Services at Brigham and Women’s Hospital, Boston, where he was also the quality officer in the NICU.

A graduate of Johns Hopkins University and the Boston University School of Medicine, Dr. Insoft completed an internship and residency in pediatrics at Massachusetts General Hospital, fellowships in neonatal-perinatal medicine and intensive care transport in the Department of Pediatrics and the Cardiovascular Research Institute at the University of California, San Francisco. He is also an executive scholar from the Brigham Leadership Program at Brigham and Women’s Hospital and Harvard Business School.

Across his career, Dr. Insoft has had the opportunity to contribute to the field of critical care transport and has taught nationally and internationally in this area. He has led the Section of Transport Medicine (SOTM) of the American Academy of Pediatrics (AAP) and is the editor in chief and senior author on the AAP National Guidelines for Air and Ground Transport of Neonatal and Pediatric Patients, published this past year.


About Women & Infants Hospital 

Women & Infants Hospital of Rhode Island, a Care New England hospital, is one of the nation’s leading specialty hospitals for women and newborns. A major teaching affiliate of The Warren Alpert Medical School of Brown University for obstetrics, gynecology and newborn pediatrics, as well as a number of specialized programs in women’s medicine, Women & Infants is the 9th largest stand-alone obstetrical service in the country and the largest in New England with approximately 8,500 deliveries per year. A Designated Baby-Friendly® USA hospital, U.S.News & World Report 2014-15 Best Children’s Hospital in Neonatology and a 2014 Leapfrog Top Hospital, in 2009 Women & Infants opened what was at the time the country’s largest, single-family room neonatal intensive care unit.

Women & Infants and Brown offer fellowship programs in gynecologic oncology, maternal-fetal medicine, urogynecology and reconstructive pelvic surgery, neonatal-perinatal medicine, pediatric and perinatal pathology, gynecologic pathology and cytopathology, and reproductive endocrinology and infertility. It is home to the nation’s first mother-baby perinatal psychiatric partial hospital, as well as the nation’s only fellowship program in obstetric medicine.

Women & Infants has been designated as a Breast Imaging Center of Excellence by the American College of Radiography; a Center of Excellence in Minimally Invasive Gynecology; a Center of Biomedical Research Excellence by the National Institutes of Health (NIH); and a Neonatal Resource Services Center of Excellence. It is one of the largest and most prestigious research facilities in high risk and normal obstetrics, gynecology and newborn pediatrics in the nation, and is a member of the National Cancer Institute’s Gynecologic Oncology Group and the Pelvic Floor Disorders Network.